Retina
Showing 26 - 50 of 2,729
Primary Indeterminate Lesions or Choroidal Melanoma
Recruiting
- Choroidal Melanoma
- Indeterminate Lesions of Eye
-
Tucson, Arizona
- +14 more
Dec 7, 2022
Diabetic Macular Edema, Retinal Disease, Macular Edema Trial in United States (Aflibercept, foselutoclax)
Not yet recruiting
- Diabetic Macular Edema
- +8 more
-
Bakersfield, California
- +7 more
Aug 23, 2023
Neovascular Age-related Macular Degeneration Trial in United States (OLX10212 is a cell penetrating asymmetric small
Recruiting
- Neovascular Age-related Macular Degeneration
- OLX10212 is a cell penetrating asymmetric small interference RNA (cp-asiRNA)
-
Santa Maria, California
- +4 more
Jan 10, 2023
Geographic Atrophy Trial in Bellaire, Dallas (OCU410)
Recruiting
- Geographic Atrophy
- OCU410
-
Bellaire, Texas
- +1 more
Aug 25, 2023
Wet Age-related Macular Degeneration Trial in Puerto Rico, United States (KSI-301, Aflibercept, Sham Procedure)
Active, not recruiting
- Wet Age-related Macular Degeneration
- KSI-301
- +2 more
-
Phoenix, Arizona
- +65 more
Jun 2, 2022
Wet Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in United States (KSI-301)
Terminated
- Wet Age-related Macular Degeneration
- +2 more
-
Phoenix, Arizona
- +10 more
Nov 1, 2022
Macular Degeneration, Geographic Atrophy Trial in Worldwide (IONIS-FB-LRx, Placebo)
Recruiting
- Macular Degeneration
- Geographic Atrophy
- IONIS-FB-LRx
- Placebo
-
Phoenix, Arizona
- +83 more
Aug 19, 2022
Diabetic Retinopathy Trial in Spain, United Kingdom, United States (BI 765128, Sham comparator)
Recruiting
- Diabetic Retinopathy
- BI 765128
- Sham comparator
-
Dothan, Alabama
- +34 more
Jan 24, 2023
Wet Macular Degeneration Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)
Neovascular Age-Related Macular Degeneration (nAMD) Trial in Worldwide (KHK4951, Aflibercept Injection)
Not yet recruiting
- Neovascular Age-Related Macular Degeneration (nAMD)
- KHK4951
- Aflibercept Injection
-
Arcadia, California
- +27 more
Oct 31, 2023
Diabetic Retinopathy Trial (Docosahexaenoic Acid and Lutein Enriched Eggs, Regular Eggs)
Recruiting
- Diabetic Retinopathy
- Type 2 Diabetes
- Docosahexaenoic Acid and Lutein Enriched Eggs
- Regular Eggs
-
Winnipeg, Manitoba, CanadaAsper Clinical Research Institute
Nov 1, 2022
Uveitis, Posterior Trial in United States (Fluocinolone Acetonide Intravitreal Implant 0.18 mg)
Recruiting
- Uveitis, Posterior
- Fluocinolone Acetonide Intravitreal Implant 0.18 mg
-
Phoenix, Arizona
- +16 more
Aug 18, 2022
Diabetic Macular Edema Trial in Latvia, United States (KSI-301, Aflibercept, Sham Procedure)
Active, not recruiting
- Diabetic Macular Edema
- KSI-301
- +2 more
-
Bakersfield, California
- +45 more
Jun 2, 2022
Diabetes, Diabetic Retinopathy, Diabetic Macular Edema Trial in Worldwide (THR-687 dose level 1, THR-687 dose level 2, THR-687
Terminated
- Diabetes Mellitus
- +2 more
- THR-687 dose level 1
- +3 more
-
Huntington Beach, California
- +24 more
Jul 19, 2022
Geographic Atrophy, Macular Degeneration Trial in United States (JNJ-81201887, Prednisone, Placebo)
Recruiting
- Geographic Atrophy
- Macular Degeneration
- JNJ-81201887
- +4 more
-
Phoenix, Arizona
- +3 more
Mar 31, 2023
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)
Active, not recruiting
- Macular Edema
- Retinal Vein Occlusion
- KSI-301
- +2 more
-
Phoenix, Arizona
- +140 more
Jul 20, 2022
Geographic Atrophy Trial in Worldwide (APL-2, Sham Procedure)
Active, not recruiting
- Geographic Atrophy
- APL-2
- Sham Procedure
-
Phoenix, Arizona
- +111 more
Jun 20, 2022
Dry Age-related Macular Degeneration, Geographic Atrophy, Macular Degeneration Trial in United States (GEM103)
Terminated
- Dry Age-related Macular Degeneration
- +4 more
-
Phoenix, Arizona
- +28 more
Mar 22, 2022
Macular Edema Secondary to Retinal Vein Occlusion Trial in Worldwide (Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose,
Not yet recruiting
- Macular Edema Secondary to Retinal Vein Occlusion
- Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose
- +3 more
-
Fullerton, California
- +311 more
Apr 28, 2023
Macular Degeneration Trial in United Kingdom, United States (BI 754132)
Terminated
- Macular Degeneration
- BI 754132
-
Beverly Hills, California
- +12 more
Aug 23, 2022
Neovascular Age-Related Macular Degeneration Trial in United States (PDS Implant filled with 100 mg/mL Ranibizumab, Intravitreal
Completed
- Neovascular Age-Related Macular Degeneration
- PDS Implant filled with 100 mg/mL Ranibizumab
- Intravitreal Injections of 10 mg/mL Ranibizumab
-
Mesa, Arizona
- +76 more
Feb 28, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in San Antonio (D-4517.2)
Recruiting
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
-
Los Angeles, California
- +11 more
Jan 11, 2023
Geographic Atrophy Trial in Worldwide (APL-2, Sham Procedure)
Active, not recruiting
- Geographic Atrophy
- APL-2
- Sham Procedure
-
Phoenix, Arizona
- +140 more
Jun 20, 2022